Palo Alto Investors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Sell |
962,396
-39,665
| -4% | -$706K | 3.64% | 10 |
|
|
2025
Q1 | $17.9M | Buy |
1,002,061
+187,870
| +23% | +$3.35M | 3.4% | 11 |
|
|
2024
Q4 | $24.3M | Buy |
814,191
+220,651
| +37% | +$6.58M | 3.76% | 9 |
|
|
2024
Q3 | $9.28M | Buy |
593,540
+31,632
| +6% | +$494K | 1.21% | 17 |
|
|
2024
Q2 | $9.63M | Hold |
561,908
| – | – | 1.12% | 17 |
|
|
2024
Q1 | $8.78M | Hold |
561,908
| – | – | 0.99% | 21 |
|
|
2023
Q4 | $8.39M | Sell |
561,908
-98,367
| -15% | -$1.47M | 0.76% | 21 |
|
|
2023
Q3 | $10.7M | Buy |
660,275
+82,157
| +14% | +$1.33M | 1.01% | 15 |
|
|
2023
Q2 | $24M | Buy |
578,118
+545,328
| +1,663% | +$22.6M | 1.94% | 12 |
|
|
2023
Q1 | $1.97M | Buy |
+32,790
| New | +$1.97M | 0.16% | 23 |
|